A growing number of anticancer therapies once available only as intravenous (IV) infusions now have subcutaneous formulations. These can shorten chair time for patients and change how infusion centers ...
I am a house pharmacist in Malaysia currently doing a clinical pharmacy rotation in the ICU. I have a few patients started on vancomycin continuous infusion instead of the conventional intermittent ...
Despite the high incidence of these reactions, strategies for optimal administration of ATG and management of these infusion reaction symptoms are not well documented in the literature. Product ...
For people living with primary immunodeficiency, immunoglobulin replacement therapy is a cornerstone of treatment. These therapies help replace missing antibodies and lower the risk of serious ...
Infusion therapy treats many conditions, including autoimmune disease, immune deficiency, infection, cancer, and chronic inflammatory disorders. Hospital ...
CHICAGO, May 31, 2024 /PRNewswire/ -- Johnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with ...
Discover the latest articles and news in related subjects. Patients who underwent allogeneic HSCT with GVHD prophylaxis consisting of the continuous infusion of CsA and short-term MTX were included.
Operational leaders in oncology know exactly how difficult it is to balance the multiple tradeoffs needed to schedule infusion services efficiently. Patients want a consistent appointment for each ...
Morning Overview on MSN
FDA adds its strongest warning to an iron infusion millions of patients receive
The Food and Drug Administration has placed its most prominent safety warning on ferric carboxymaltose, sold in the United States as Injectafer, an intravenous iron treatment given in outpatient ...
MAINZ, Germany, & MAHWAH, N.J.--(BUSINESS WIRE)--SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, and KORU Medical Systems (NASDAQ: KRMD), a leading medical ...
In December 2023, CMS directed A/B MACs not to make downward adjustments to claims for CPT Codes for complex therapy administration (96401-96549) based solely on the specific drug being administered.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results